BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 31484281)

  • 1. A well differentiated neuroendocrine tumor of the jejunum with peritoneal carcinomatosis: A case report.
    Antoniadou F; Korkolis D; Koufopoulos N; Manatakis D; Sakellariou S
    Mol Clin Oncol; 2018 Dec; 9(6):651-655. PubMed ID: 30546896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergent expression of DCLK1 in gastrointestinal neuroendocrine tumors and primary hepatic, gallbladder, and pancreatic neuroendocrine tumors.
    Fan M; Yan H; Gou M; Qian N; Dai G
    Int J Clin Exp Pathol; 2020; 13(9):2249-2258. PubMed ID: 33042329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological Features of Gastroenteropancreatic Neuroendocrine Neoplasms.
    Sekerci A; Turk HM; Demir T; Seker M; Akcakaya A; Arici DS
    J Coll Physicians Surg Pak; 2020 Aug; 30(8):863-867. PubMed ID: 32893801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Postoperative Chemotherapy on the Survival of Patients with High-Grade Gastroenteropancreatic Neuroendocrine Carcinoma.
    Schmitz R; Mao R; Moris D; Strickler JH; Blazer DG
    Ann Surg Oncol; 2021 Jan; 28(1):114-120. PubMed ID: 32556871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRRT in high-grade gastroenteropancreatic neuroendocrine neoplasms (WHO G3).
    Sorbye H; Kong G; Grozinsky-Glasberg S
    Endocr Relat Cancer; 2020 Mar; 27(3):R67-R77. PubMed ID: 31846429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms?
    Merola E; Rinke A; Partelli S; Gress TM; Andreasi V; Kollár A; Perren A; Christ E; Panzuto F; Pascher A; Jann H; Arsenic R; Cremer B; Kaemmerer D; Kump P; Lipp RW; Agaimy A; Wiedenmann B; Falconi M; Pavel ME
    Ann Surg Oncol; 2020 May; 27(5):1348-1355. PubMed ID: 31720931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine tumor G3 of bronchopulmonary origin and its classification.
    Kasajima A; Klöppel G
    Pathol Int; 2022 Oct; 72(10):488-495. PubMed ID: 35983917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent updates on grading and classification of neuroendocrine tumors.
    Kim JY; Hong SM; Ro JY
    Ann Diagn Pathol; 2017 Aug; 29():11-16. PubMed ID: 28807335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
    Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
    BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathologic features and prognostic analysis of 240 patients with gastric neuroendocrine neoplasms].
    Liang WQ; Zhang W; Qiao S; Wang BH; Wang C; Zhuang ZW; Xi HQ; Cai AZ; Wei B; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Jan; 23(1):38-43. PubMed ID: 31958929
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinicopathological characteristics and prognosis analysis of colorectal neuroendocrine neoplasms based on the data from domestic six medical centers].
    Zhang Y; Peng X; Jin K; Wang W; Feng X; Zeng Y; Chen M; Yu X; Chen Y; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1235-1240. PubMed ID: 27928792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathological classification and prognostic factors of gastrointestinal neuroendocrine neoplasms: an analysis of 119 cases].
    Ma X; Zhao W; Zhuang C; Wang X; Tu L; Wang M; Sun Y; Cao H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):997-1001. PubMed ID: 28900989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathological features and multivariate analysis of prognostic factors for patients with gastroenteropancreatic neuroendocrine tumors].
    Wang X; Song ZF; Yao WX; Pan CC; Xiang MF; Wang H
    Zhonghua Yi Xue Za Zhi; 2013 May; 93(18):1411-4. PubMed ID: 24025507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathological features and prognosis of 488 patients with neuroendocrine tumors].
    Zhai XJ; Yu SL; Ma YH; Wang F; Yang MJ; Lian YJ; Yu XX; Fan QX; Song LJ
    Zhonghua Yi Xue Za Zhi; 2019 Aug; 99(32):2527-2531. PubMed ID: 31484281
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.